Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ESSA Pharma ( (EPIX) ) has shared an update.
ESSA Pharma Inc. has introduced a new Severance Plan, replacing previous cash severance benefits for certain executive officers. This plan offers cash severance ranging from 1 to 1.5 times an officer’s base salary, with additional compensation for the CEO, tied to events like a Change in Control. The plan aims to retain key executives by providing economic security in case of qualifying terminations, ensuring stability and encouraging dedication to the company’s growth.
Find detailed analytics on EPIX stock on TipRanks’ Stock Analysis page.